Old Web
English
Sign In
Acemap
>
Paper
>
The Resource Cost of Switching Stable Rheumatology Patients From An Originator Biologic To A Biosimilar In The UK
The Resource Cost of Switching Stable Rheumatology Patients From An Originator Biologic To A Biosimilar In The UK
2017
Theresa Barnes
Ernest Wong
K Thakrar
F Glen
Steven Young-Min
K Marchbank
A. Ingram
Keywords:
Biosimilar
Physical therapy
Rheumatology
Medicine
Internal medicine
Intensive care medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
1
Citations
NaN
KQI
[]